Hauser, Christoph VictorChristoph VictorHauser0000-0002-2413-8931Kronenberg, Andreas OskarAndreas OskarKronenberg0000-0002-0006-7833Allemann, AurélieAurélieAllemann0000-0002-9113-2118Mühlemann, KathrinKathrinMühlemannHilty, MarkusMarkusHilty0000-0002-2418-64742024-10-242024-10-242016-05-26https://boris-portal.unibe.ch/handle/20.500.12422/142562Concurrent analysis of antibiotic resistance of colonising and invasive Streptococcus pneumoniae gives a more accurate picture than looking at either of them separately. Therefore, we analysed 2,129 non-invasive and 10,996 invasive pneumococcal isolates from Switzerland from 2004 to 2014, which spans the time before and after the introduction of the heptavalent (PCV7) and 13-valent (PCV13) conjugated pneumococcal polysaccharide vaccines. Serotype/serogroup information was linked with all antibiotic resistance profiles. During the study period, the proportion of non-susceptible non-invasive and invasive isolates significantly decreased for penicillin, ceftriaxone, erythromycin and trimethoprim/sulfamethoxazole (TMP-SMX). This was most apparent in non-invasive isolates from study subjects younger than five years (penicillin (p = 0.006), erythromycin (p = 0.01) and TMP-SMX (p = 0.002)). Resistant serotypes/serogroups included in PCV7 and/or PCV13 decreased and were replaced by non-PCV13 serotypes (6C and 15B/C). Serotype/serogroup-specific antibiotic resistance rates were comparable between invasive and non-invasive isolates. Adjusted odds ratios of serotype/serogroup-specific penicillin resistance were significantly higher in the west of Switzerland for serotype 6B (1.8; 95% confidence interval (CI): 1.4-4.8), 9V (3.4; 95% CI: 2.0-5.7), 14 (5.3; 95% CI: 3.8-7.5), 19A (2.2; 95% CI: 1.6-3.1) and 19F (3.1; 95% CI: 2.1-4.6), probably due to variations in the antibiotic consumption.enStreptococcus pneumoniaeantibiotic resistanceepidemiologyinvasive pneumococcal diseaseserotypesurveillance500 - Science::570 - Life sciences; biology600 - Technology::610 - Medicine & healthSerotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014.article10.7892/boris.835992725453510.2807/1560-7917.ES.2016.21.21.30239